Leading through AI:
Where momentum is lost and how leaders regain it
WHEN THIS BECOMES CRITICAL
AI initiatives are increasing but impact is unclear
Decision-making is slowing as complexity rises
Leadership teams are stretched across competing priorities
Pressure to deliver remains unchanged
A SIMPLE WAY TO THINK ABOUT IT
AI Impact = Clarity × Ownership × Capacity
WHAT ACTUALLY MAKES THE DIFFERENCE
Organisations have the AI capability (or are steadily building these). Its implementation fails because organisations don’t change how they operate
Decision-making remains too slow
Ownership remains unclear
Leadership attention remains fragmented
Instead of AI creating efficiencies, its exposes these issues
What we see high-performing teams doing differently
Treat AI as an operating model shift, not a tech initiative
Redesign decision-making, not just workflows
Create space for change, rather than layering it on
AI is accelerating change across pharma, but most organisations are still operating with models designed for stability. As the pressure builds, execution becomes even harder and organisations need to adapt quickly to make an impact.
WHERE MOMENTUM BREAKS
Siloed AI initiatives with a lack of clear ownership
Governance slows decisions
Leaders must transform & deliver simultaneously
Teams experiment but can’t scale
THE COST OF NOT ADDRESSING IT
Execution slows despite strong capability
Leaders spend time reconnecting decisions instead of moving forward
Fragmented initiatives dilute impact
Confidence erodes across teams and stakeholders